SCHEMBL532836

SCHEMBL532836

Cc1cc(C)c(N2CCC(C)CC2)c(C)c1NS(=O)(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 3/20 0.42
TP53 P04637 2/20 0.42
MAPT P10636 3/20 0.42
GAA P10253 2/20 0.42
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 5/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
BRPF1 P55201 1/20 0.41
UQCRB P14927 2/20 0.41
F10 P00742 1/20 0.41
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533091 0.89 BRPF1 (0.52) HSD17B2TP53MAPTGAAKDM4E
SCHEMBL14288685 0.83 HSD11B1 (0.45) HSD17B2TP53MAPTMAPK1L3MBTL1
SCHEMBL533017 0.76 FFAR4 (0.55) TP53MAPTGAAL3MBTL1KDM4E
SCHEMBL8320623 0.76 BRPF1 (0.48) TP53MAPTMAPK1KDM4EPOLB
SCHEMBL533025 0.75 ACLY (0.45)
SCHEMBL533666 0.74 FFAR4 (0.56) TP53MAPTGAAMAPK1L3MBTL1
SCHEMBL532880 0.74 FFAR4 (0.56) TP53MAPTGAAMAPK1L3MBTL1
SCHEMBL533437 0.74 CYTH2 (0.49) TP53MAPTGAAMAPK1KDM4E
SCHEMBL533055 0.74 ALDH1A1 (0.45) MAPTKDM4EPOLBALDH1A1TDP1
SCHEMBL532776 0.73 FFAR4 (0.54) TP53MAPTGAAL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed